Ethanol elicits and potentiates nociceptor responses via the vanilloid receptor-1
Marcello Trevisani(University of Ferrara), Pierangelo Geppetti(Azienda Ospedaliero-Universitaria Careggi), George Davey Smith(Medical Research Council), Andrew D. Randall(GlaxoSmithKline (United Kingdom)), Stephen Brough(GlaxoSmithKline (United Kingdom)), Martin J. Gunthorpe(GlaxoSmithKline (United Kingdom)), Davina E. OWEN(GlaxoSmithKline (United Kingdom)), Michele Tognetto(University of Aberdeen), Julie Gray(GlaxoSmithKline (United Kingdom)), Mario Barbieri, Silvia Amadesi(University of California, San Francisco), Barbara Campi(University of Ferrara), Antonio Bianchi(University of Catania), S. Harrison(University of Ferrara), Jeffrey C. Jerman(GlaxoSmithKline (United Kingdom)), D Smart(GlaxoSmithKline (United Kingdom)), Janet L. Davis(University of California, Los Angeles)
Cited by 446
Related Papers
Body-mass index and all-cause mortality: individual-participant-data meta-analysis of 239 prospective studies in four continents
|The Lancet|2016|2.8k
Interpretation of the evidence for the efficacy and safety of statin therapy
|The Lancet|2016|1.8k
Evaluating the potential role of pleiotropy in Mendelian randomization studies
|Human Molecular Genetics|2018|1.7k
An endogenous capsaicin-like substance with high potency at recombinant and native vanilloid VR1 receptors
|Proceedings of the National Academy of Sciences|2002|963
Agonists of proteinase-activated receptor 2 induce inflammation by a neurogenic mechanism
|Nature Medicine|2000|931